Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Herpesvirus 1, Human | 7 | 2025 | 83 | 1.280 |
Why?
|
| Viral Structural Proteins | 3 | 2025 | 17 | 0.870 |
Why?
|
| Virus Assembly | 4 | 2019 | 54 | 0.790 |
Why?
|
| Viral Proteins | 3 | 2025 | 270 | 0.730 |
Why?
|
| Capsid | 2 | 2025 | 104 | 0.680 |
Why?
|
| Virus Replication | 4 | 2025 | 323 | 0.650 |
Why?
|
| Herpesvirus 8, Human | 2 | 2017 | 17 | 0.620 |
Why?
|
| Chromosomes, Artificial, Bacterial | 2 | 2018 | 19 | 0.600 |
Why?
|
| Genome, Viral | 3 | 2018 | 144 | 0.580 |
Why?
|
| Amino Acids | 1 | 2019 | 148 | 0.560 |
Why?
|
| Herpesviridae | 1 | 2018 | 15 | 0.560 |
Why?
|
| Integrases | 1 | 2018 | 41 | 0.550 |
Why?
|
| Sequence Deletion | 1 | 2018 | 115 | 0.550 |
Why?
|
| Recombination, Genetic | 2 | 2018 | 256 | 0.540 |
Why?
|
| Sarcoma, Kaposi | 1 | 2017 | 17 | 0.510 |
Why?
|
| Tracheal Stenosis | 1 | 2016 | 9 | 0.500 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2016 | 7 | 0.500 |
Why?
|
| Adenoma | 1 | 2016 | 70 | 0.480 |
Why?
|
| Oncolytic Virotherapy | 2 | 2025 | 9 | 0.400 |
Why?
|
| Oncolytic Viruses | 2 | 2025 | 10 | 0.400 |
Why?
|
| Capsid Proteins | 3 | 2017 | 107 | 0.330 |
Why?
|
| Vero Cells | 5 | 2025 | 81 | 0.300 |
Why?
|
| Nuclear Envelope | 1 | 2025 | 49 | 0.220 |
Why?
|
| Tumor Microenvironment | 1 | 2025 | 183 | 0.210 |
Why?
|
| Glioblastoma | 1 | 2025 | 161 | 0.200 |
Why?
|
| Immunotherapy | 1 | 2025 | 274 | 0.190 |
Why?
|
| Brain Neoplasms | 1 | 2025 | 318 | 0.180 |
Why?
|
| Virion | 1 | 2019 | 122 | 0.140 |
Why?
|
| Reverse Genetics | 1 | 2018 | 10 | 0.140 |
Why?
|
| Virology | 1 | 2018 | 13 | 0.140 |
Why?
|
| Cell Culture Techniques | 1 | 2019 | 195 | 0.140 |
Why?
|
| Receptor, Notch3 | 1 | 2017 | 10 | 0.130 |
Why?
|
| Hemangioma | 1 | 2017 | 27 | 0.130 |
Why?
|
| Blood Vessels | 1 | 2017 | 63 | 0.130 |
Why?
|
| Animals | 9 | 2025 | 21345 | 0.130 |
Why?
|
| Open Reading Frames | 1 | 2017 | 84 | 0.130 |
Why?
|
| Electrocoagulation | 1 | 2016 | 13 | 0.120 |
Why?
|
| Rare Diseases | 1 | 2016 | 45 | 0.120 |
Why?
|
| Bronchoscopy | 1 | 2016 | 88 | 0.120 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 134 | 0.120 |
Why?
|
| Stem Cells | 1 | 2017 | 276 | 0.120 |
Why?
|
| Phenotype | 1 | 2019 | 1233 | 0.110 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2017 | 570 | 0.110 |
Why?
|
| Gene Transfer Techniques | 1 | 2017 | 325 | 0.110 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 896 | 0.110 |
Why?
|
| Genomics | 1 | 2017 | 384 | 0.100 |
Why?
|
| Cell Line, Tumor | 3 | 2025 | 1565 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1386 | 0.090 |
Why?
|
| Mutation | 1 | 2019 | 2661 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 2483 | 0.080 |
Why?
|
| Genetic Vectors | 1 | 2017 | 918 | 0.080 |
Why?
|
| Neoplasms | 1 | 2020 | 1368 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2016 | 2102 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 1656 | 0.070 |
Why?
|
| Luminescent Proteins | 2 | 2017 | 129 | 0.060 |
Why?
|
| Humans | 5 | 2025 | 65140 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2016 | 5792 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2017 | 500 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2025 | 203 | 0.060 |
Why?
|
| Mice | 3 | 2025 | 11119 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2025 | 283 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 2293 | 0.040 |
Why?
|
| Cell Line | 2 | 2016 | 2024 | 0.040 |
Why?
|
| Injections, Intralesional | 1 | 2020 | 14 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 64 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2020 | 293 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 372 | 0.040 |
Why?
|
| Transgenes | 1 | 2020 | 204 | 0.040 |
Why?
|
| Middle Aged | 1 | 2016 | 18273 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2017 | 14 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2017 | 34 | 0.030 |
Why?
|
| Pericytes | 1 | 2017 | 17 | 0.030 |
Why?
|
| Antigens | 1 | 2017 | 145 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 203 | 0.030 |
Why?
|
| Color | 1 | 2016 | 26 | 0.030 |
Why?
|
| Cricetinae | 1 | 2017 | 362 | 0.030 |
Why?
|
| Protein Engineering | 1 | 2016 | 85 | 0.030 |
Why?
|
| Plasmids | 1 | 2017 | 294 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2017 | 208 | 0.030 |
Why?
|
| Chromosomes | 1 | 2017 | 139 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2017 | 541 | 0.030 |
Why?
|
| Male | 1 | 2016 | 31047 | 0.030 |
Why?
|
| Mitosis | 1 | 2017 | 222 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 372 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2016 | 202 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2017 | 616 | 0.030 |
Why?
|
| Spodoptera | 1 | 2014 | 27 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2016 | 506 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2020 | 713 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 794 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 198 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2017 | 1038 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 1220 | 0.020 |
Why?
|
| Protein Transport | 1 | 2014 | 405 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2017 | 714 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 676 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2017 | 742 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 1630 | 0.020 |
Why?
|
| Protein Binding | 1 | 2014 | 1640 | 0.020 |
Why?
|
| Female | 2 | 2020 | 34018 | 0.020 |
Why?
|